Doxorubicin Market Rising Trends, Revenue Demand, Growth Drivers, Challenges, Future Opportunities and Forecast Analysis till 2034: SPER Market Research

Tue, 04 Mar 2025 10:04:42 +0000

Doxorubicin (DOX) is a generic medication used in chemotherapy to treat cancer. It is administered intravenously as an injectable solution or in lyophilised powder form using a peripherally inserted central line catheter (PICC) or central venous catheter. DOX is rapidly removed by enzymes and undergoes hydrolytic breakdown in plasma following intravenous injection. It is used to treat a variety of cancers, including breast cancer, bladder cancer, Kaposi's sarcoma, lymphoma, Wilms tumour, non-Hodgkin lymphoma, and acute lymphocytic leukaemia.